Laura Caroline Tavares Hastenteufel et al. Nadine Clausell Jeruza Lavanholi Neyeloff Fernanda Bandeira Domingues … Larissa Gussatschenko Caballero Eneida Rejane Rabelo da Silva Lívia Adams Goldraich
Abstract
Selected clinically stable patients with heart failure (HF) who require prolonged intravenous inotropic therapy may benefit from its continuity out of the intensive care unit (ICU). We aimed to report on the initial experience and safety of a structured protocol for inotropic therapy in non-intensive care units in 28 consecutive patients hospitalized with HF that were discharged from ICU. The utilization of low to moderate inotropic doses oriented by a safety-focused process of care may reconfigure their role as a transition therapy while awaiting definitive advanced therapies and enable early ICU discharge.